Konsoula Z, Barile FA. Epigenetic histone acetylation/deacetylation and experimental models of neurodegenerative disorders. J Phar Tox Methods 2012; 66 (3): 215-20. Konsoula Z, Velena A, Lee R, Dritschilo A, Jung M. Histone Deacetylase Inhibitor: Anti-Neoplastic Agent and Radiation Modulator. Adv Exp Med Biol 2011; 720: 171-9. Konsoula Z, Hong C, Velena A, Jung M. Adamantyl histone deacetylase inhibitor, H6CAHA, exhibits favorable pharmacokinetics and augments the prostate cancer radiation sensitivity. Int J Radiat Oncol Biol Phys 2011; 79 (5): 1541-8. Konsoula Z, Hong C, Velena A, Jung M. Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors. Mol Cancer Ther 2009; 8(10):2844-51. Konsoula Z, Jung M. Involvement of p-glycoprotein and multidrug resistance associated protein 1 on the transepithelial transport of a mercaptoacetamide-based histone-deacetylase inhibitor in Caco-2 cells. Biol Ph